
CorMedix Inc
CRMDNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$8.41
Day High
$8.48
Day Low
$8.26
Prev. Close
$8.42
VolumeShares traded today.
990.34K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$662.13M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
3.99
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$17.43
52W LowLowest price over the past 52 weeks.
$6.13
50D MAAverage closing price over the last 50 trading days.
$7.43
200D MAAverage closing price over the last 200 trading days.
$9.52
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+4.7%1M
+12.8%6M
-10.2%YTD
-30.6%1Y
-30.5%About
Taurolidine/heparin, sold under the brand name Defencath, is a fixed-dose combination catheter lock solution used for central venous catheter instillation. It contains taurolidine, a thiadiazinane antimicrobial; and heparin, an anti-coagulant. Its use is limited to people with kidney failure receiving chronic hemodialysis through a central venous catheter.
cormedix.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade CRMD
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.